How many jobs does DocMorris plan to reduce under its AI-driven efficiency programme?

DocMorris is implementing a reduction of around 100 full-time equivalents across the Group. The company said local statutory procedures will be initiated immediately, and that affected employees will receive support and appropriate severance packages.

How much recurring cost savings is DocMorris targeting from the announced measures?

DocMorris is targeting recurring cost savings of at least CHF 15 million per year. The company said the savings will be fully phased in by the end of 2027, will be 100 per cent cashflow-positive and will be largely reflected in EBITDA.

What one-off costs will DocMorris incur from the efficiency measures?

DocMorris said the implementation will incur one-off, extraordinary costs of CHF 5 million in the second quarter of 2026. The company said these costs will already have a positive impact on adjusted operating profit in the second half of 2026.

How will artificial intelligence change DocMorris’s operations?

DocMorris said it will use artificial intelligence and Agentic AI tools to optimise and automate workflows across all areas of the company. According to the company, this is intended to free up capacity so that resources can be directed more towards customer-facing services and innovation.

Which customer-facing businesses remain part of DocMorris’s platform strategy?

DocMorris said its platform strategy continues to centre on online pharmacy, telemedicine, retail media, marketplace and the AI health assistant. The company described these as its proven pillars for customers.

How does DocMorris’s CEO explain the efficiency programme?

CEO Walter Hess said technology enables DocMorris to optimise workflows across the company and improve efficiency through consistent automation. He described the initiative, together with the recently completed consolidation at the logistics centre in Heerlen, as a step towards increasing profitability, and said the process would be managed in a socially responsible manner.

What does DocMorris’s CFO say the efficiency improvements will achieve?

CFO Daniel Wüest said the announced efficiency improvements would strengthen DocMorris’s cost-related and organisational foundations for the planned profitable growth in the coming years. This statement is management’s explanation of the intended effect of the measures.

What does DocMorris say about revenue growth in the second quarter of 2026?

DocMorris said revenue growth in the second quarter of 2026 further accelerated compared with the first quarter, particularly in prescription medicines (Rx) and digital services. The company referred to its press release of 12 May when communicating this update.

When will DocMorris publish further information on its second-quarter 2026 performance?

DocMorris said it will publish a trading update for the second quarter of 2026 on 15 July 2026. It also said the third-quarter 2026 trading update is scheduled for 15 October 2026.

When will DocMorris report its 2026 half-year results and discuss the impact of the measures?

DocMorris said its 2026 half-year results will be communicated on 19 August 2026 through a conference call and webcast. The company said the update will also detail the impact of its positive business performance and the announced measures on its 2026 guidance.

When and where will DocMorris hold its next Capital Markets Day?

DocMorris said its Capital Markets Day will take place on 12 November 2026 in Heerlen, Netherlands. The company said an invitation with further details will follow in due course.

What does DocMorris do and how does its business operate?

DocMorris AG is a Swiss-based company operating in online pharmacy, telemedicine and marketplace services, with strong brands in Germany and other European countries. It said deliveries are mainly made from its highly automated logistics centre in Heerlen, while TeleClinic connects patients with more than 6,500 doctors and the Group operates health and personal care marketplaces in Southern Europe.

Where are DocMorris AG shares listed and what is the ticker symbol?

The shares of DocMorris AG are listed on the SIX Swiss Exchange. The source gives securities number 4261528, ISIN CH0042615283 and ticker DOCM.

Home
News Intelligence
DocMorris AG
DocMorris announces AI-driven efficiency programme with 100 FTE reduction

Back to all DocMorris AG press releases

DocMorris AG

SIX:DOCM

DocMorris announces AI-driven efficiency programme with 100 FTE reduction

Published Thursday, 25 June 2026, 05:00 AM

Get alerts

Plain English summaries when DocMorris AG announces news.

At a glance

Company: DocMorris AG
Listings: SIX:DOCM
Announcement type: Operational update
Published: Thursday, 25 June 2026, 05:00 AM
Source announcement: eqs-news.com

Key figures
Measure	Figure	Period
Reduction of around 100 full-time equivalents (FTEs)	around 100 full-time equivalents (FTEs)	Not stated
One-off, extraordinary costs	CHF 5 million	the second quarter of 2026
Recurring cost savings	at least CHF 15 million annually	annually

Figures are quoted from this announcement and selected automatically.

FAQSIR Generated from this announcement View original release below for safe harbor and regulatory notices

Announcement Summary

DocMorris AG (ticker DOCM) announced accelerated implementation of its AI-First strategy through AI-driven efficiency measures.

It targets recurring cost savings of at least CHF 15 million annually through workflow optimization and automation.
The program involves reducing around 100 full-time equivalents across the Group; local statutory procedures will begin immediately.
The company expects one-off extraordinary costs of CHF 5 million in the second quarter of 2026.
DocMorris expects a positive adjusted operating profit impact in the second half of 2026.
DocMorris says savings will be fully phased in by the end of 2027, 100 per cent cashflow-positive and largely reflected in EBITDA.

DocMorris scheduled a Q2 trading update for July 15, 2026, half-year results for August 19, 2026, a Q3 trading update for October 15, 2026, and a Capital Markets Day in Heerlen for November 12, 2026.

Investor FAQs

DocMorris announced an accelerated implementation of its “AI-First” strategy, including AI-driven optimisation and automation across extensive processes. The measures include a group-wide reduction of around 100 full-time equivalents (FTEs), targeted recurring cost savings of at least CHF 15 million annually and one-off costs of CHF 5 million.

Source announcement

Company: DocMorris AG
Title: DocMorris announces accelerated implementation of its “AI-First” strategy; positive cost savings of at least CHF 15 million per year
Published: Thursday, 25 June 2026, 05:00 AM
Source site: eqs-news.com

Read the source announcement on eqs-news.com

FAQSIR's summary and investor FAQs are generated by AI from the text of this announcement alone, without information from other sources.

Figures, forecasts and other claims are the announcement's, not FAQSIR's. FAQSIR does not independently verify them.

Read the original press release

Full text as published, unedited.

Loading the original release…

Important Notice And Disclaimer

This article was generated by an artificial intelligence system from an announcement published by the issuer. It has not been independently researched, verified, or edited by a journalist, and no person holds editorial responsibility for its wording.

The issuer named in this article has not paid for this page and has no commercial relationship with its publisher. This is an unpaid evaluation preview produced from announcements the issuer published publicly, and it is not independent editorial coverage.

This article does not provide any financial advice and is not a recommendation to deal in any securities or product. Investments may fall in value and an investor may lose some or all of their investment. Past performance is not an indicator of future performance.

Ask about this announcement

Answers drawn only from this announcement

Reading the announcement…